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The past few years have seen remarkable progress in our understanding of embryonic stem cell (ES cell) biology. The necessity of
examining human ES cells in culture, coupled with the wealth of genomic data and the multiplicity of cell lines available, has enabled
researchers to identify critical conserved pathways regulating self-renewal and identify markers that tightly correlate with the ES cell state.
Comparison across species has suggested additional pathways likely to be important in long-term self-renewal of ES cells including
heterochronic genes, microRNAs, genes involved in telomeric regulation, and polycomb repressors. In this review, we have discussed
information on molecules known to be important in ES cell self-renewal or blastocyst development and highlighted known differences
between mouse and human ES cells. We suggest that several additional pathways required for self-renewal remain to be discovered and these
likely include genes involved in antisense regulation, microRNAs, as well as additional global repressive pathways and novel genes. We
suggest that cross species comparisons using large-scale genomic analysis tools are likely to reveal conserved and divergent paths required
for ES cell self-renewal and will allow us to derive ES lines from species and strains where this has been difficult.
Published by Elsevier Inc.
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A detailed description of early embryo development is
beyond the scope of this review and readers are referred to
excellent reviews by Dr. Gilbert (Developmental Biology,
Sinauer Press) on species differences in early blastocyst
development. A brief summary of blastocyst and inner cell
mass (ICM) maturation is shown in Fig. 1. The primary
trophoblast lineage segregates from the lineage of the
embryo proper first followed by segregation of the
hypoblast (extraembryonic endoderm) and mesoderm fol-0012-1606/$ - see front matter. Published by Elsevier Inc.
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E-mail address: raomah@grc.nia.nih.gov.lowed by amniotic endoderm. The epiblast or the embryo
proper forms the embryonic ectoderm followed by the
development of the primitive streak that leads to differ-
entiation of mesoderm and endoderm that then differentiate
into specific tissues and organs. It is important to note that
primordial germ cells (PGC) develop early and are
segregated extraembryonically (to the yolk sac) as the
embryo develops further. The PGCs then migrate into the
embryo proper and are localized to the gonadal ridges.
PGCs retain Oct3/4 expression and acquire specific germ
cell markers (reviewed in Johnson et al., 2003a; McLaren,
2003). ES cells are derived from the ICM of blastocyst
before implantation and these cells retain many of the
characteristics of ICM cells although unlike the ICM, which
is a transient structure that rapidly differentiates, ES cells
can be maintained relatively indefinitely in culture (Buehr
and Smith, 2003). ES cells recapitulate the development275 (2004) 269–286
Fig. 1. Blastocyst development. A schematized sequence of development adapted from Gilbert’s Developmental Biology is shown. Note the time period of
development and the identified stages of differentiation that suggest that pluripotent cells of varying characteristics could be harvested depending on the method
and time of isolation.
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by many of the same factors that regulate germ layer
formation and cell type specification (Burdon et al., 2002;
Loebel et al., 2003; Tiedemann et al., 2001). ES cells have
been used successfully to identify regulatory pathways that
direct differentiation (see for example Kikuchi et al., 2004)
and confirming the role of a particular pathway in vivo
using genetically manipulated mouse cells.
It is important to note, however, that pluripotent cells
have been isolated from early blastocysts as well as from
embryoid bodies and from germ cells (Papaioannou et al.,
1984; Rossant and Papaioannou, 1984; Shamblott et al.,
2001; Thomson and Odorico, 2000). These cells appear
similar in their expression of Oct3/4 and their ability to
contribute to multiple somatic tissues and germinal deriv-
atives but likely differ in their imprinting status (Onyango,
2002), their ability to differentiate into extraembryonic
tissue, and their relative frequency of contribution to
chimeras after blastocyst injection. The relatively large time
window from which cells can be isolated coupled with the
dynamic changes that are taking place during this same time
window perhaps explaining both the success in obtaining
ES or ES-like lines has been reported from species as
divergent as medaka and human as well as the difficulty in
obtaining ES lines from some strains of mice, pigs, and rats.
Further, species differences in development, differences in
timing of isolation, and the variability in the types of cell
that are potentially multipotent ensure that any pluripotent/
totipotent cell lines obtained, while similar overall, will
differ in subtle ways.
Most of our knowledge of ES cell biology is derived
from studies performed in mouse embryos and ES cells
(Carter et al., 2003; Tanaka et al., 2002; reviewed in Ko,2004). In human embryos, information is limited to the
detailed information on early blastocyst maturation,
sequence of differentiation, and factors required for matura-
tion and maintenance of blastocysts in culture that has been
developed by IVF clinics. More recently, however, gene
expression data developed by analyzing human ES cell lines
(Abeyta et al., 2004; Bhattacharya et al., 2004; Branden-
berger et al., 2004 a,b; Richards et al., 2004; Sperger et al.,
2003) have provided additional insights.
Given the variation in early blastocyst maturation and the
uncertainty in the stage at which the pluripotent cell
population is isolated, it is possible that comparing across
species may provide useful insights. Such comparisons may
help distinguish between critical and redundant regulatory
components required to maintain the pluripotent ES cell’s
state. In this review, we have summarized known pathways
of ES cell self-renewal and identified potential additional
pathways that are likely to be important and suggested how
detailed inter- and intra-species comparisons may provide
useful insight into generating and maintaining ES cells. The
data on mouse ES cell self-renewal and known pathways are
discussed first and comparisons are highlighted in subse-
quent sections.Factors that maintain the ES cell state
A brief overview of mouse ES cell self-renewal is shown
in Fig. 2 (see also Niwa, 2001) At this stage of development,
most regulatory factors are either derived from the ES cells
themselves or from cells that differentiate from them or from
feeder cells that are required to maintain cells in culture.
Current data suggest that more than one growth factor is
Fig. 2. ES cell self-renewal. A simple model of ES cell self-renewal and its potential regulation is shown. Positive and negative regulators act in concert to
determine whether cells will self-renew or differentiate. Factors likely act over short term as well as over long term to maintain the ES cell phenotype.
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inhibited by the absence of differentiation genes as well as
the presence of active repressors. It is likely that long-term
self-renewal that is characteristic of ES cells requires
additional specialized machinery to regulate genomic
stability, epigenetic gene patterns, telomeric ends, and some
aspect of a clock to maintain appropriate timing of lineage
segregation as well as choosing between symmetric and
asymmetric division (for a review, see Sommer and Rao,
2002). Knowledge of some of these pathways is surprisingly
detailed while that of others is relatively sparse. Indeed,
despite the widespread use of mouse ES cells and the
successful isolation of ES cells from a variety of species,
relatively little attention has been paid to identifying the
regulators of self-renewal or determining why the efficiency
of ES cell derivation is so species and strain dependent
(Ishiwata et al., 2001; Meng et al., 2003). Nevertheless,
much has been learned from examining well-characterized
mouse ES cell lines and several factors involved in their
self-renewal have been identified. Much of our knowledge
has come from mouse ES cell lines (Burdon et al., 2002;
Loebel et al., 2003) and more recently by comparison with
human ES cell lines (Carpenter et al., 2003; Ginis and Rao,
2003; Richards et al., 2004), and these and other recent
results are discussed below.LIF–BMP–OCT–Sox pathways
LIF, serum, and BMP
The most critical pathways regulating self-renewal in
mouse ES cells are those mediated by Oct3/4 and leukemia
inhibitory factor (LIF), and a model of their interaction has
been proposed by Niwa (2001). LIF, a member of the LIF–oncostatinM–Il-6 superfamily of cytokines, is critical for
maintenance of feeder-free ES cell lines. LIF acts by binding
to a LIFR–gp130 signaling complex that activates at least
two downstream pathways: a Jak–STAT (Janus kinase,
signal transducer and activator of transduction) pathway and
an ERK–MEK–ras–raf pathway (Fig. 3). Experiments have
shown that it is the activation of the Jak–STAT pathway that
is critical for ES self-renewal (Niwa et al., 1998). Activation
of STAT3 in the absence of LIF is sufficient for prolonged
self-renewal (Matsuda et al., 1999) and activation of a
modified receptor, which lacks the ability to activate the
erk–MEK–ras–raf pathway, is as efficient (better) as the
wild-type receptor in maintaining cells in an undifferentiated
state (Burdon et al., 1999a; Burdon et al., 1999b). LIF
signaling probably requires activation of c-abl and over-
expression of bcr–abl allows for LIF-independent self-
renewal (Table 1). The activation of the LIF pathway can
be modulated by thrombopoietin acting via its receptor c-
mpl probably at the level of STAT3 (Xie et al., 2002) and by
insulin like growth factor-2 (IGF2) acting via the IGF
receptor(s) (Takahashi et al., 1995; Viswanathan et al.,
2003). CD9, a cell surface protein that is activated by LIF
signaling, is likely important in LIF-mediated self-renewal
as well (Oka et al., 2002).
LIF, however, does not act alone and an as yet unknown
factor present in serum is required for efficient maintenance
of ES cells. This serum factor is likely to be bone
morphogenetic protein (BMP) acting via the bone morpho-
genetic protein receptor1 (BMPR1) and receptor activating
SMADs (mothers against dpp related) as shown by recent
experiments showing prolonged self-renewal in serum-free
medium supplemented with BMP and LIF (Ying et al.,
2003; Brandenberger et al., submitted). BMPs likely act via
BMPR1a, which is expressed at high levels in ES, cell
cultures, and is downregulated when ES cells differentiate
Fig. 3. LIF and BMP interactions. Potential interactions between LIF and BMP signaling pathways are shown. Note that these pathways can interact at multiple
levels and suggest several candidate perturbation strategies. Highlighted in red are known modes of interaction that have not shown to be either expressed,
active, or important in ES cells.
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renewal is dependent on the presence of LIF. In its absence,
BMP is a strong inducer of mesodermal differentiation and
an inhibitor of neuronal differentiation. Potential interac-
tions between the LIF and BMP signaling pathways are
summarized in Fig. 3. Interactions may occur at several
different levels. FKBP12 may mediate interactions at the
receptor level. Protein inhibitor of activated signaling
(PIAS) may mediate interaction at the cytoplasmic mes-
senger level while SMADS and STATS may interact with
CPB ((CRE-binding protein)-binding protein)/p300 to regu-
late binding to appropriate signaling sites. Downstream
modulating signals likely include suppressor of cytokine
signaling (SOCS) and inhibitory SMADs (iSMADs), which
in turn can regulate ligand signaling through appropriate
receptors providing for a feedback regulatory loop. The
importance of these interactions has been shown in other
cell types including glial differentiation (Bright and Sriram,
1998; Nakashima et al., 1999; Rajan et al., 2003). It is
unclear whether such interactions occur in ES cells. Never-
theless, components of each of these pathways as well as
interacting molecules have been shown to be elevated in
human and mouse cells (Rao, unpublished results).
Oct3/4 signaling
Equally important to maintaining the ES cell state is an
octamer motif binding transcription factor Oct3/4. Most ES
lines (with the possible exception of chicken cells) express
high levels of Oct3/4 and precise levels of this gene are
required to maintain the ES cell state and both over-
expression and downregulation will alter ES cell fate
(reviewed in Niwa, 2001 and references therein). While
other members of the Oct family are widely expressed, the
expression and binding of Oct3/4 are relatively specific toES and germ cells, and its levels are regulated at the mRNA
level (Donovan, 2001; Nishimoto et al., 2003). The
promoter region of Oct3/4 has been well characterized,
and proximal and distal enhancers, which are conserved
across multiple species, have been identified. The proximal
enhancer appears to be required for ES cell expression while
the distal enhancer appears critical for germ cell expression
(Pesce and Scholer, 2000, 2001). Binding sites for multiple
transcription factors including the Sox family of transcrip-
tional regulators have been identified Zhan et al., personal
communication), and it has been shown that Oct3/4 is
negatively regulated by retinoic acid (RA) signaling and
possibly by TRIF (Toll/interleukin-1 receptor (TIR) domain-
containing adapter protein) (Fuhrmann et al., 1999).
Methylation likely regulates the spatial and temporal
expression of this critical regulator of ES cell self-renewal
(Hattori et al., 2004). Their results link regulation of the
chromatin structure of the Oct-4 gene by DNA methylation
status and by extension DNA-N-methyl transferase
(DNMTs) (DNMT3h is another ES enriched gene) to
regulating ES gene expression and highlight the importance
of epigenetic mechanisms (discussed below). It is unclear as
to what acts as a positive regulator to maintain appropriate
levels of Oct3/4. No conserved Oct-Sox co-binding sites are
present, and it is unlikely that Oct regulates its own
expression directly. Likewise, no conserved STAT3 binding
sites or FGF response element (FRE) or Nanog (Homeo-
domain) binding sites have been identified. How extrac-
ellular signals regulate Oct3/4 expression thus remains
unknown. RA directly downregulates Oct3/4 expression
and may be important in initiating differentiation.
Oct3/4 itself cooperates with other transcription factors to
positively and negatively regulate downstream gene expres-
sion (summarized in Fig. 4). Oct3/4 binds to an Octamer
motif in the promoter or enhancer regions of many ES cell-
Table 1
Candidate genes that may be important in maintaining ES cells
Gene Reference Phenotype
LIF related
BCR-abl (Coppo et al., 2003) Overexpression activates STAT3 and allows
LIF independent self-renewal
CD-9 (Oka et al., 2002) Downstream of LIF activation
Thrombopoietin and c-MPL (Xie et al., 2002) Can activate Stat3 and may synergize with LIF
BMP (Ying et al., 2003) Cooperates with LIF to sustain self-renewal
Igf2 (Takahashi et al., 1995) Cooperate with LIF to sustain self-renewal
FGF related
FGFR1 (Deng et al., 1994; Esner et al., 2002) Blocks maturation of visceral endoderm and cavitation
FGF (Chen et al., 2000) Blockade inhibits embryoid body differentiation
FGFR2 (Arman et al., 1998) Preimplantation abnormalities
O-linked carbohydrates (Jirmanova et al., 1999) Absence reduces cell proliferation
Other pathways
Nanog (Mitsui et al., 2003) ES cell self-renewal independent of Oct and LIF
E-Hox (Jackson et al., 2002) Essential for differentiation
PARP-1 (Hemberger et al., 2003) Biased to trophoblast giant cells
Eras (Takahashi et al., 2003) Essential for ES cell proliferation
Dicer (Bernstein et al., 2003) Embryonic lethal and failure to generate ES lines
PEM (Fan et al., 1999) Overexpression inhibits differentiation
E-cadherin (Oloumi et al., 2004) Interacts with Wnt and integrin pathways
Rad51–XRCC2 (Tsuzuki et al., 1996) Appears critical for ES cell growth
Interferon gamma (Zou et al., 2000) Induces cell death
makorin (Du et al., 2001; Hirotsune et al., 2003) Downstream of Oct3/4 signaling, expressed
pseudogene regulates gene expression
CD98 (Tsumura et al., 2003) Embryonic lethal when knockouts made
SRp20 (Jumaa et al., 1999) Mice fail to form blastocysts
h-1 integrin (Stephens et al., 1995) Impairs post implantation development
Evx-1 (Spyropoulos and Capecchi, 1994) Early embryonic lethality
NrOB1–DAX (Clipsham et al., 2004) Lethal in ES cells involved in germ cell development
EZH2–eed complex (O’Carroll et al., 2001) Failure to implant or derive ES cell lines
GlcNAC-1 phosphotransferase (Marek et al., 1999) Preimplantation embryonic lethality
MLL (Ayton et al., 2001) Preimplantation lethality in homozygous nulls
Moesin (Doi et al., 1998) No phenotype but synctiaum formation abnormal
ESP (Lee et al., 1996) ES cell specific phosphatase
MicroRNAs (Houbaviy et al., 2003) ES specific MicroRNAs noted
Fbx15 (Tokuzawa et al., 2003) Knockout has no phenotype
asrij (Mukhopadhyay et al., 2003) No phenotype reported
Jumonji (Toyoda et al., 2000) High in ES cells and a negative regulator for growth
Hsp90alpha &h (Voss et al., 2000) Hsp90h null fail to develop placental labyrinth
Raly (Michaud et al., 1993) Preimplantation embryonic lethality
Glut1 and Glut 3 (Saijoh et al., 1996) Downstream of Oct-3
Molecules that are either highly expressed, required, or affect ES cell or blastocyst development are listed. Note not all known genes are listed, rather a
representative subset was selected to illustrate the multiple pathways that are likely critical in regulating ES cell proliferation.
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of Oct3/4 is critical to maintaining a self-renewing ES cell.
Experiments modulating Oct3/4 levels have shown that
precise levels of Oct3/4 expression are required to maintain
ES cells in an undifferentiated state. Oct3/4 probably
interacts with other transcription factors to regulate down-
stream genes, and some interactions have been delineated. A
cooperative binding mechanism has been proposed where
Sox2 and Oct3/4 bind to adjacent domains and regulate
expression. Indeed, Sox-Oct sites have been found adjacent
to each other in regulatory regions of Sox2, Utf1 (undiffer-
entiated cell transcription factor 1), Rex1–zfp42 (zinc finger
protein-42), FGF4 (fibroblast growth factor-4), and so forth
(Nishimoto et al., 1999; Tomioka et al., 2002; Yuan et al.,1995; Zeng et al., 2004), and several additional genes that
have been shown to be important in ES cell self-renewal or
differentiation. In addition to Oct–Sox cooperative binding,
interaction between FoxD3 (forkhead family member D3)
and Oct has also been reported (Guo et al., 2002;
Shivdasani, 2002). How critical is the expression of FoxD3,
Rex1, Utf1, and other ES cell-enriched transcription factors
in maintaining ES cell self-renewal and whether their role is
conserved in human ES cells is unclear. FoxD3, for
example, appears to be nonessential, and differing expres-
sion has been reported in various human ES cell lines (Ginis
et al., 2004; Richards et al., 2004). Likewise, Rex1 is
present at high levels in most human ES cell lines but was
shown to be absent in HES4 (human ES cell line designated
Fig. 4. Summary of pathways. Oct3/4 activation of downstream genes and potential interactions with other pathways regulating ES cell-specific gene
expression are shown.
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(Fbx15), a gene known to be highly expressed in mouse ES
cells and regulated by Oct3/4, appears to be dispensable in
knockout mice and is absent or expressed at undetectable
levels in human ES cells (Bhattacharya et al., 2004;
Tokuzawa et al., 2003). Sox binding sites are present in
the Oct3/4 promoter and suggest a potential regulatory
interaction as well (Zhan et al., personal communications).
How LIF extracellular regulatory pathways interact with
the Oct–Sox pathway is unknown. Many of the genes that
are regulated by Oct–Sox signaling also contain STAT
binding sites, suggesting that these two pathways could act
cooperatively in regulating the expression of ES cell-
specific genes at the transcriptional level (Fig. 4). LIF itself
does not appear to regulate Oct3/4 and Oct3/4 does not
appear to regulate Jak–STAT signaling, suggesting that the
Oct3/4 pathway is a parallel pathway for maintaining self-
renewal. A possible additional mechanism by which LIF–
STAT signaling may interact with Oct3/4 is suggested by a
recent report describing Oct1–Stat5 interactions. Magne et
al. (2003) have recently shown that Stat5 contains a motif in
its carboxyl terminal that is similar to the POU interacting
motif on two well known partners of Oct1 (obf-1–Bob and
Snap90), suggesting that a physical interaction between
these factors stabilizes the binding of Stat5 to its consensus
binding motif. A similar motif is present in Stat3, and
thrombopoietin, which activates Stat5 (Kirito et al., 2002)
and modulates ES cell self-renewal (Xie et al., 2002), can
modulate the effect of LIF on ES cell self-renewal.
A potential candidate ribonuclear protein has been
identified, originally called Dppa5 (Astigiano et al., 1991;
Bierbaum et al., 1994) that was then independently cloned
by Tanaka et al. (2002) and named embryo specific gene 1(ESG1). We have cloned the human homologues of ESG1
and shown that it is highly expressed in human ES cells and
is downregulated as ES cells differentiate as much as in
mouse ES cells (Ginis et al., 2004; unpublished data). ESG1
appears to be downstream of both LIF and Oct3/4 pathways
(Tanaka et al., 2002), and its downregulation as cells
differentiate is more rapid than that of Oct3/4 or Nanog,
indicating that this gene may be a useful marker of the
undifferentiated cell state. How ESG1 integrates Oct3/4 and
LIF signaling remains to be determined.
In summary, the data suggest that two parallel pathways
exist that are required to maintain mouse ES cells. The LIF–
Stat3 pathway is modulated by the BMP pathway likely at
multiple levels and interacts with the Oct3/4 pathway to
maintain ES cell self-renewal. Oct3/4 levels are precisely
maintained and how this is achieved remains unclear. Much
is known about downstream interactors of Oct3/4 signaling;
however, little is known about upstream regulators and it is
unlikely that Oct3/4 regulates its own expression directly.
The Oct3/4 pathway appears conserved in most species
(with the exception of chicken ES cells), while components
of the LIF pathway appear to be redundant in some human
ES cells. LIF and Oct pathways appear to converge on
common downstream targets that include many ES cell-
specific genes and suggest potential autoregulatory circuits.FGF, Nanog, and other pathways
FGF signaling
Although, LIF is critical to maintaining mouse ES cells
in culture, experiments generating LIF receptor-null, gp130-
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and ES cell lines can be established. These data provide
compelling evidence that factors other than LIF are
important in the ICM and that pathways independent of
LIF–gp130 signaling may be sufficient to maintain undif-
ferentiated ES cells (Berger and Sturm, 1997; Gendall et al.,
1997). Candidate factors that may be important remain
elusive although a series of experiments suggest that FGF
acting via fibroblast growth factor receptors (FGFRs) may
be important. Modulation of FGF signaling as in FGFR1-
and FGFR2-null mice or in FGF 2 mutants (Chen et al.,
2000; Deng et al., 1994; Esner et al., 2002) alters blastocyst
development, cavitation, or differentiation. FGF4 is required
for appropriate differentiation, its expression is regulated by
Oct3/4, and in the absence of FGF4 endoderm, differ-
entiation is altered (Wilder et al., 1997). Receptor binding of
FGFs is modulated by extracellular matrix (ECM) mole-
cules and O-linked carbohydrates on ECM molecules
appear to be important at this early stage of differentiation
(Jirmanova et al., 1999). More recently, it has been shown
that human cells can be maintained with FGF in the absence
of LIF (reviewed in Carpenter et al., 2003). This finding is
consistent with the possibility that this may be a candidate
alternate pathway. Whether FGFs could substitute for LIF in
maintaining mouse ES cells or whether some other pathway
exists is unclear. FGFRs are present on mouse ES cells and
can be activated by external FGF application (see above,
and data not shown), and it appears that this question can be
rapidly addressed. Known downstream mediators of FGF
signaling are summarized in Fig. 5. Two aspects of FGF
signaling may be of particular relevance to ES cell self-
renewal. Recently, Dr. Ghosh et al. showed that FGF2
facilitates access of the STAT–CBP complex to the GFAP
promoter by inducing Lys4 methylation and suppressing
Lys9 methylation of histone H3 at the STAT binding site
(Song and Ghosh, 2004). This FGF-mediated regulation of
chromatin remodeling provides a possible mechanism byFig. 5. FGF signaling. Potential downstream signaling pathways are shown. Note
has been shown to regulate TERT expression as well though this is not shown in th
that have not been shown to our knowledge to be important in ES cells.which FGF can regulate multiple ES cell-specific genes and
permit the self-renewal of ES cells in the absence of LIF. In
addition, Haremaki et al. (2003) showed that Xcad3, a gene
downstream to FGF activation, may contain an FRE. The
authors showed that an FRE was comprised of juxtaposed
Ets and TCF–LEF binding sites that served to integrate
FGF-mediated signaling with that of other growth factors. In
a detailed functional and physical analysis, the authors
showed that FGF, BMP, and Wnt signals are integrated on
these FREs through positively acting Ets and Sox family
transcription factors and negatively acting TCF–LEF family
transcription factor(s). Whether these two pathways can be
extended to ES cell cultures remains unknown. It is
interesting, however, that Ets family transcription factors
are expressed at high levels in ES cells (unpublished data)
and, recently, Wnt and TGF have been suggested as
important in regulating human and mouse ES cell self-
renewal.
Nanog and other homeobox proteins
Recently, a factor that may act in parallel to maintain ES
cell self-renewal has been identified (Chambers et al., 2003;
Mitsui et al., 2003). This homeobox domain-containing
protein was initially identified as a gene highly expressed in
ES cells (Wang et al., 2003). Two groups subsequently
showed that it is required for mouse cell self-renewal called
Nanog (after Tir a nanog or land of the ever young). Nanog
was shown to be essential for self-renewal of ES cells and
overexpression was sufficient to maintain Oct3/4 levels.
Nanog acts in concert with LIF but does not modulate the
LIF signaling pathway and does not seem to be involved in
the BMP regulatory pathway either (Chambers et al., 2003;
Mitsui et al., 2003). How Nanog and Oct3/4 signals
converge downstream remains to be determined. How
Nanog expression is regulated remains unknown, and it is
unlikely that LIF or Oct3/4 directly regulates Nanogpotential interactions with STATs, histones, Wnts, and IGF signaling. FGF
is figure. Highlighted in red are genes known to modulate the FGF pathway
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via binding to a homeobox domain in downstream target
genes (Pan and Pei, 2003; Zhang et al., 2004). Potential
downstream targets include Rex and GATE6 (Chambers et
al., 2003). Nanog expression is high in human ES cells as
well (Bhattacharya et al., 2004) and is downregulated as the
cells differentiate. Zhang et al. (2004) have shown that
potential Nanog binding sites exist in several genes that are
expressed in ES cells and that TGF h signaling family may
be regulated by Nanog. It is interesting to note that another
homeobox domain containing protein E-Hox (ES specific
homeodomain protein) is important in ES cell differentiation
(Jackson et al., 2002). This protein when overexpressed
inhibits differentiation and its expression levels appear high
in mouse ES cells. No human ortholog of E-Hox exists and
the most closely related paralogs are not expressed in human
ES cells (Zhang et al., 2004). E-Hox appears, however, to be
a member of a large family that includes several genes that
are important in early development, and it is possible that
the function of E-Hox is performed by another family
member. Overall, the data suggest that Nanog represents a
relatively independent pathway that is required in both
mouse and human cells. Nanog is also expressed by rat ES-
like cells, and the gene appears relatively well conserved.
Other homeobox proteins are likely important as well, but it
is likely that the particular family member expressed will be
dependent on the species.
Wnt and TGFb1 signaling
Recently, Sato et al. showed pluripotency in human and
mouse embryonic stem cells through activation of Wnt
signaling (see Fig. 6) by a pharmacological GSK-3-specific
inhibitor (Glycogen-synthetase Kinase, Sato et al., 2004).Fig. 6. Wnt signaling. The canonical pathway and its interaction with cadherins ar
cytoplasm, or nucleus, and multiple pathways act to regulate its levels and location.
not been shown to our knowledge to be important in ES cells. In blastocysts, cadh
(see text).The authors found that activation of the Wnt pathway by 6-
bromoindirubin-3V-oxime (BIO), a specific pharmacological
inhibitor of glycogen synthase kinase-3 (GSK-3), maintains
the undifferentiated phenotype in both types of ES cells and
sustains expression of the pluripotent state-specific tran-
scription factors Oct3/4, Rex1, and Nanog. The authors
found that Wnt signaling is endogenously activated in
undifferentiated murine ES cells and is downregulated upon
differentiation, suggesting that GSK-3 inhibition is main-
tained by Wnt signaling. These results are supported by
earlier results by Shibamoto et al. (2004), which showed that
a blockade of Wnt signaling was activated when F9
teratomacarcinoma cells were induced to differentiate.
Expressed sequence tags (EST) scan analysis of human ES
cells and massively parallel signature sequencing (MPSS)
analysis of mouse and human cells suggest that the major
components of theWnt pathway are represented in detectable
levels in undifferentiated cell cultures (unpublished results,
Bhattacharya et al., 2004; Brandenberger et al., 2004a). A
potential additional interaction between Wnt and ECM
signaling is suggested by the known effect of E-Cadherin
on preventing h-catenin nuclear localization and h-catenin–
LEF-1-mediated transactivation (Orsulic et al., 1999).
Expression of E-cadherin is seen in the epiblast and appears
important in regulating differentiation in several tissue types
and is important in regulating the localization and levels of h-
catenin (summarized in Fig. 6 and reviewed in Oloumi et al.,
2004). Absence of E-cadherin in E-cadherin/ embryonic
stem (ES) cells leads to an accumulation of free h-catenin
and its association with LEF-1 (T cell factor–lymphocyte
expressed factor), thereby mimicking Wnt signaling.
The Nodal–TDGF1–Cer-1 signaling pathway is involved
in ES cell differentiation (Fig. 7), impacting left–right axis
formation, neural patterning, and mesoderm developmente shown. Note that h-catenin performs differing functions at the membrane,
Highlighted in red are genes known to modulate the Wnt pathway that have
erins and their interaction with h-catenin have been shown to be important
Fig. 7. TGFh signaling. Potential TGFh signaling pathways are highlighted. Note the multiple steps at which positive and negative regulators can modulate
receptor–SMAD–fox signaling. Members of this extensive family shown in the figure have been shown to be present, active, or important in ES cell or
blastocyst development.
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(teratoma derived growth factor 1), and Cer-1 (Cerberus 1)
are all expressed in ES cells. TDGF1, an Epidermal growth
factor–cryptic family (EGF–CFC) family member, is an
obligate coreceptor or a coligand for Nodal (Yan et al.,
2002). Amit et al. (2004) in a separate set of experiments
used a defined medium, feeder-free, and serum-free
condition to assess the role of other factors. Their results
suggest that in a defined medium when cells are grown on
fibronectin with 15% serum replacement medium, addition
of LIF, TGFh1, and FGF is sufficient to maintain human ES
cells over multiple passages in an undifferentiated state.
Cells retain the expression of ES cell markers and the ability
to form teratomas after implantation in immune compro-
mised mice. These results are consistent with the known
expression of molecules in this signaling pathway during
early development and in ES cell cultures. Moreover,
several modulators of signaling are expressed early as well
(see Fig. 7), including Nodal, lefty and TDGF1, Cer-1, and
so forth. TDGF1 can alter proliferation of teratomacarci-
noma cells (Baldassarre et al., 1997), consistent with the
idea that TGF1 signaling may regulate cell proliferation. In
addition, genes downstream of TGF superfamily signaling
are upregulated in cultured ES cells (Zeng et al., 2004).
However, TGFh1, activin, and other members of the family
are thought to promote differentiation and inhibit prolifer-
ation as well (Shiner et al., 2003), raising the possibility that
the results may be specific to the particular combination of
culture conditions used.
Overall, these results suggest that FGF, Wnt, and TGFh
are likely important candidates in regulating ES-cell self-
renewal. Wnt likely acts via the canonical pathway and its
effect can be modulated by integrins and cadherins, andTCEF–LEF may interact downstream with the FRE provid-
ing an additional mechanism of interaction. TGFh likely
signals thru SMADs and Forkhead-related family members.
It is important to note that BMP, Wnts, and TGFs have been
shown to regulate multiple aspects of ES cell differentiation
as well, and it is likely that levels of the cytokines, their
interaction with other molecules, and the overall state of the
ES cells will determine if cells respond with self-renewal or
initiation of differentiation. It will be important as with BMP
(see above) to assess the effect in culture with appropriate
cofactors that modulate or alter their activity, and these
results highlight the importance of developing defined
culture conditions to compare results across laboratories.
Other pathways that regulate preimplantation development
or ES cell self-renewal
In addition to LIF–FGF–Oct3/4–BMP and Nanog,
several other molecules that modulate preimplantation
development or prevent derivation of ES cells lines or
whose loss causes embryonic lethality have been identified.
A list of candidate molecules is shown in Table 1, and some
of the pathways that these may reflect are discussed below.
These include signaling molecules such as Eras, homeobox
domain containing proteins such as evx (even skipped
homeobox), and E-Hox, molecules that modulate LIF and
FGF pathways as well as metabolic regulators such as cell
cycle regulators and so forth. While it is clear that these
molecules are important in blastocyst development or ES
cell self-renewal, it is unclear how these factors are
regulated or interact with known signaling pathways and
significant work will be required to delineate interactions
between these molecules.
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Over the past few years, the importance of heritable
epigenetic remodeling has been highlighted in regulating
stem cell proliferation, cell fate determination, and carcino-
genesis (Beaujean et al., 2004; Huntriss et al., 2004;
Meehan, 2003; Ohgane et al., 2004; Vignon et al., 2002).
These pathways summarized briefly in Fig. 8 are likely
important in early embryonic development as well. HDACs
and methyl-CpG-binding protein (MECPs ) are expressed in
ES cells and their levels are dynamically regulated as cells
differentiate (Christodoulou and Weaving, 2003; Young and
Zoghbi, 2004; and data not shown). Further, as discussed
above, FGF that is critical for maintaining human ES cells
may regulate gene expression by histone acetylation. In
addition, Hattori et al. (2004) have shown that methylation
of CpG islands is important in the expression of Oct3/4.
These investigators showed that Oct3/4 activity was
undetectable and severely repressed in trophoblastic lineage,
including stem cells, and that treatment with 5-aza-2V-
deoxycytidine (5-aza-dC) or trichostatin A (HDAC regu-
lators) caused activation of the Oct-4 gene. The authors
further showed that in the placenta of Dnmt1 null mutant
mice, most of the CpGs in the enhancer–promoter region
were unmethylated and Oct-4 gene expression was aber-
rantly detected and that Oct-4 enhancer–promoter region
was hyperacetylated in ES cells compared to TS (tropho-
ectoderm) cells. Finally, in vitro methylation suppressed the
Oct-4 enhancer–promoter activity in a reporter assay. This
demonstrates that DNA methylation status is closely linked
to chromatin structure of the Oct-4 gene. Further evidenceFig. 8. Epigenetic remodeling. Possible epigenetic pathways to regulate gene expre
or methylated. Methylation of genomic DNA at CpG island and modulation of hist
cell type-specific gene expression. Genes shown in the figure have been shown tof methylation regulating gene expression in ES cells is
provided by Liu et al., who showed that the alpha subunit of
human chorionic gonadotrophin was silenced by methyl-
ation that was directed by direct binding of the Oct3/4
protein to the site responsible for silencing (Liu et al., 1997).
Other investigators (Hori et al., 2002) have identified a dyad
Oct-binding sequence that functions as a maintenance
sequence for the unmethylated state within the H19–Igf2-
imprinted control region, providing further evidence of
importance of methylation. In ES cells, specific demethy-
lases DNMT3h and DNMT3L appear to be expressed at
high levels (Bhattacharya et al., 2004) and are rapidly
downregulated upon differentiation, and expression of these
genes is critical for nuclear reprogramming (Huntriss et al.,
2004). Interestingly, DNMT3L appears to be expressed
during oogenesis in mice, while it begins to be expressed
only after fertilization in humans. This suggests differential
regulation of methylation in these species (Huntriss et al.,
2004).
The importance of methylation of CpG islands as well as
histones in regulating gene expression during development
has been recognized (Chow and Brown, 2003; Sims et al.,
2003). Its role in regulating X inactivation and in imprinting
(reviewed in Hemberger, 2002; Monk, 2002) and in
appropriate development after somatic nuclear transfer
(Bortvin et al., 2003; Rideout et al., 2001; Tucker et al.,
1996; Wutz and Jaenisch, 2000) has been described. An
additional role for Polycomb repressors such as enhancer of
zeste homolog and early embryonic ectoderm (eed) that
bind to chromatin and regulate gene expression has also
been identified (Chadwick and Willard, 2003; Okamoto et
al., 2004; Silva et al., 2003). Eed-Enx1 Polycomb groupssion are schematized. Note that histones can be acetylated, phosphorylated,
one interactions with other transcriptional regulators can all serve to regulate
o be present, active, or important in ES cell or blastocyst development.
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imprinted X inactivation in the trophectoderm lineage in
mouse but also for recruitment of Eed-Enx1 to the inactive
X chromosome (Xi) in random X inactivation in the embryo
proper. Localization of Eed-Enx1 complexes to Xi occurs
very early, at the onset of Xist expression, but then
disappears as differentiation and development progress
(Silva et al., 2003). Overall, the data suggest that epigenetic
remodeling may regulate multiple aspects of stem cell self-
renewal, thus providing a mechanism for integrating and
coordinating multiple signals directing self-renewal versus
differentiation. Comparison between mouse and human
suggests that many of these pathways are similar, and
genes, which cause embryonic lethality in mouse embryos,
are expressed in human ES cells and are downregulated as
ES cells differentiate.
Cell cycle Rb and myc, and pathways regulating telomere
ends
ES cells possess unique properties in that they appear
spontaneously immortal, can be maintained as a karyotypi-
cally stable cell in undifferentiated culture conditions for
prolonged periods, do not show contact inhibition, express
high levels of telomerase, and maintain telomere length, and
when transplanted in immune-compromised animals gen-
erate teratomas. These properties, which are relatively
unique to ES cells, suggest that the pathways regulating
long-term self-renewal and transition through the cell cycle
may be unique to or modulated differently in ES cells.
Several investigators have examined cell cycle protein
expression in ES cells (see review by Burdon et al.,
2002). ES cells appear to have a short G1-S transition, and
Rb (retinoblastoma gene), which is critical in regulating this
transition in most dividing cells, appears to be inactive
(hyperphosphorylated or present at low levels). Other Rb-
related proteins (p107 and p130) appear to be low or absent
as well (unpublished results). Further, mouse ES cells
appear refractory to growth inhibition by P16ink4a, triple KO
ES cells where all three Rb family genes are knocked out
show normal growth rates, and DNA damage does not lead
to arrest at G1 as is typical of all other dividing cells. In
addition, it appears unlikely that the ras–raf–erk pathway
that transduces cytokine proliferation signals to cell cycle
machinery plays an important role in regulating ES cell
division (Jirmanova et al., 2002). Potential regulatory
pathways that have been suggested to regulate ES cell
proliferation include a novel ras family member Eras whose
overexpression is sufficient to maintain cell proliferation
and whose expression is limited to ES cells (Takahashi et
al., 2003), a PI3K (phosphoinositide-3 kinase)-mediated
regulation of cyclins (Pacold et al., 2000; Sun et al., 1999),
and myc activation (Davis and Bradley, 1993; MacLean-
Hunter et al., 1994) that appears to regulate proliferation.
Myc activation rather than the ras–raf–erk pathway may be
critical in linking cytokine signaling to the cell cycle as mycoverexpression can render cells cytokine independent
(Shirogane et al., 1999; S. Dalton, personal communica-
tion), and myc expression and activation can be detected in
human ES cells. Myc-null ES cell lines can, however, be
generated (Davis and Bradley, 1993; MacLean-Hunter et
al., 1994), suggesting that compensatory pathways exist.
Data on human ES cells are still incomplete, but prelimi-
nary expression data by MPSS and EST scan analysis
(Brandenberger et al., 2004a,b; Ginis et al., 2004) suggest
that as in mouse cells the Rb pathway is relatively
unimportant while the PI3K and myc pathways are active.
No perturbation experiments, however, have been per-
formed to our knowledge.
Given the ability of ES cell to self-renew for prolonged
periods, one would predict that telomerase activity will be
present and tightly regulated. Mouse ES cells, however, can
be obtained from telomerase reverse transcriptase (TERT)
KO mice, and these cells can be maintained in culture.
Blastocysts from TERT KO mice appear to implant and
develop normally for several generations (reviewed in
Cheong et al., 2003). This ability may be unique to mice,
which have unusually long telomeres and may not be
generalized to other species. Indeed, human ES cells express
all the major components of the TERT pathway and levels
of some of these components are dynamically regulated as
cells differentiate. TERT assays have shown that TERT
levels are downregulated as cells differentiate but main-
tained if cells are kept in non-differentiating conditions over
at least 2 years (Carpenter et al., 2004; Rosler et al., 2004).
Perturbation experiments knocking down TERT activity in
human cells remain to be performed.
In summary, we would suggest that the cell cycle is
regulated differently in ES cells, and this differential
regulation appears to include many critical aspects of cell
cycle control including Rb, p53, ras, myc, and the DNA
repair machinery. Many of these unique aspects are shared
between mouse and human ES cells; however, some
differences exist (Ginis et al., 2004). These differences
include the pathway by which Rb is regulated, how
telomerase activity is regulated, and how the cell cycle
pathway is coupled to growth factor signaling (see above).
MicroRNAs and antisense regulation
MicroRNAs are small noncoding RNA genes found in
most eukaryotic genomes and are involved in the post-
transcriptional regulation of gene expression. The micro-
RNAs are transcribed in the cell nucleus where they are
processed into pre-microRNAs. Further processing occurs
in the cytoplasm, where the pre-microRNAs are cleaved
into their final approximately 22-nucleotide-long form
summarized in Fig. 9. MicroRNAs appear to be processed
by Dicer, and double-stranded RNAs appear to regulate
gene expression via transcriptional, translational, or protein
degradation regulation (Bartel, 2004; Szymanski and
Barciszewski, 2003). Recent reports have identified global
Fig. 9. MicroRNAs. Processing of microRNA is summarized in Panel A. Components shown are present in mouse and human ES cells. Panels B and C
summarize possible pathways of heterochronic gene regulation as identified in C. elegans. Lin 41, Lin 28, and binding domains for Let-7 and Lin-4 have been
identified in mouse and human ES cells.
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untranslated RNAs have been identified (see for example
Houbaviy et al., 2003; Lewis et al., 2003; Rajewsky and
Socci, 2004) and in particular showed that several micro-
RNAs were ES cell specific and were downregulated as
cells differentiate or absent in differentiated tissue. Other
expression data have suggested that these microRNAs are
dynamically expressed at specific stages and may play an
important role in cell fate and differentiation in multiple
species (Chen et al., 2004). Knockouts of Dicer show
embryonic lethality at early stages of development, and it
has not been possible to derive ES cell lines from Dicer-null
embryos (Bernstein et al., 2003), further confirming the
importance of this pathway. Functionally, at least two
microRNAs play a role in regulating timing of development
in C. elegans, lin-4 and let-7, both of which have been
identified as being expressed in ES cells (Zhan et al.,
personal communication). In C. elegans, these microRNAs
bind to conserved sequences in the untranslated region
(UTR) of genes involved in regulating the appropriate
timing of differentiation (Banerjee and Slack, 2002). This
heterochronic pathway includes Lin-28 and Lin-41 (John-
son et al., 2003b; Moss and Tang, 2003), and recent
microarray and serial analysis of gene expression (SAGE)
analysis has suggested that the human homologues of these
genes are highly expressed in undifferentiated ES cells
(Bhattacharya et al., 2004; Brandenberger et al., 2004b;
Richards et al., 2004). Examination of their three prime
UTR shows that Lin-4 and Let-7 sites are evolutionarily
conserved as well (Zhan et al., personal communication),
suggesting that this pathway may be important in regulating
ES cell self-renewal and differentiation.Some recent results suggest that antisense RNA may also
regulate gene expression and ES cell self-renewal. Perhaps
the clearest example comes from the expression of TSIX,
which is antisense to XIST, and makorin, which is an Oct3/4-
regulated gene that is antisense to RAF1 (serine–threonine
protein kinase). Both TSIX and makorin 2 are expressed at
early stages of development and at relatively high levels in
ES cells. Alteration of XIST and makorin alters development
(Chow and Brown, 2003; Gray et al., 2001; Hirotsune et al.,
2003). In addition to makorin2 being antisense to RAF1, a
phylogenetically conserved genomic orientation (Gray et al.,
2001), a processed pseudogene of makorin has also been
identified (Hirotsune et al., 2003). Knockdown of either
makorin or its pseudogene affects development and dedif-
ferentiation, and the phenotype can be rescued by either gene,
suggesting that RNA stability is being regulated by makorin.
Given that makorin and its antisense partner RAF1 are both
expressed in human andmouse ES cells and that makorin was
earlier identified as a downstream target of Oct3/4 (Du et al.,
2001), it suggests that antisense regulation of gene expres-
sion may be an important aspect of maintenance of the stem
cell state and that other such examples may exist. While it is
clear that many components of these pathways are shared
between mouse and human ES cells, relatively little is known
and further comparisons await additional data.Conserved and divergent pathways and additional
unknown pathways
The ability to compare ES cells from human and mice
has allowed one to assess conserved pathways likely to be
Table 3
Some known differences between mice and human ES cells
Divergent signaling pathways
LIFR–gp130 LIFR gene regulatory domains not well
conserved, expression divergent in mouse
and human
Eras and EHox Conserved in mouse and rat no functional
ortholog in humans
Fox-D3 Required in mice but expression variable in
human cell lines
Rex1 Variable expression in human ES cell lines
FGF signaling FGF2 appears high in human ES cells while
FGF4 is high in mouse ES cells. SNP in
FGF4 alters Sox-Oct binding in three prime
UTR of hFGF4.
Lefty A No orthologue in mice or rats identified
SSEA antigen Differential expression seen
Tert signaling and
aging associated genes
Several components of this pathway are
differentially expressed
Fbx15 Does not appear to be expressed in human
ES cells
Cell cycle and cell death Ubiquitination seems important in regulating
human Rb levels while mdm2 appears more
important in mouse. Likewise pattern of
caspases and other cell death genes expressed
are quite distinct
Expression of Mouse ES cells do not differentiate into
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conserved pathways is listed in Table 2. Nanog, Oct3/4,
Sox, Rex, Utf, TERT, connexin, Glut-1, Dicer, DNMT, and
so forth all appear to be conserved and are likely to be
important in ES cell self-renewal. Interestingly, the hetero-
chronic gene regulatory pathway appears to be highly
conserved as well. Assessing BMPR, Wnt, TGFh, and other
pathways suggests that the effect of BMPR1 postulated in
mES cells is likely true in human ES cell cultures as well.
The pathway appears conserved, as does downstream
signaling via SMADS. In contrast, the Wnt and TGFh
signaling pathways do not appear to be conserved in the
same manner. Wnts appear to affect differentiation in mouse
cell, as does TGFh, while these molecules appear to be
important in maintaining primate ES cell self-renewal (see
above). Nevertheless, the conservation of key pathways
suggests a core ES cell identity that is conserved across
species. This core identity would include Oct, Sox, Rex,
Utf, TERT, and so forth and will be clearly distinct from
genes expressed in other badult–non-ESQ stem cell popula-
tions. We suggest that additional conserved pathways
probably remain to be identified. Note that several develop-
ment and pluripotency associated genes (Dppa) wereTable 2
Conserved pathways of self-renewal in mice and humans
Conserved signaling pathways
Stat3 signaling Evolutionarily conserved gene, STAT binding sites
present in multiple ES cell specific genes
Nanog Shown to be critical in both mouse and human,
rat gene not yet cloned
Oct-Sox Conserved genes and cobinding sites conserved,
Oct3/4 not present in chick
BMPR1a Cooperates with LIF to sustain self-renewal,
function conserved in human and mouse
TGFh signaling Cripto, nodal, lefty appear to show similar patterns
of expression and function though some
differences exist
Igf2–H19 Highly expressed in both mice and human ES cells
FGF signaling Critical for blastocyst development in mice and
required for human ES cell. Differences in which
FGF used likely
MicroRNAs Dicer required for blastocyst development, expressed
in human ES cells, and heterochronic gene
expression (Lin-28) conserved
Methylation–X
Inactivation
Polycomb genes (EZH2–eed complex, Xist,
TSIX, DNMT3h and DNMT3-like show
conserved patterns of expression
Cell cycle While differences exist both human and mouse ES
cells show distinct Rb regulation when compared
to other cell types
Others DNA repair machinery, telomerase biology,
some aspects of cell death, and several novel
gene pathways (Dppa2, 4 and so forth)
are likely conserved.
A list of genes or pathways known to be important in mouse and human ES
cells is summarized. Data on the importance of these pathways in human
ES cells and is largely based on high levels of expression in multiple lines
and downregulation as cells differentiate.
trophoblast markers trophoblast while human cells appear to do
so and express early trophoblast markers in
maintenance conditions
Claudin 6 Shows a reverse pattern of expression. High
in ES and low in EB in human
Decorin Differentially expressed in mouse and human
ES cells
NROB1 steroid (NROB1–DAX) axis appears
divergent
Others MPSS analysis show very low concordance
in gene expression suggesting multiple
additional differences exist
Pathways known to be important in mouse ES cells that are either not
critical or appear to not be evolutionarily conserved are listed.identified based on early embryonic expression, and recent
work has confirmed the importance of some of these genes
including Dppa3/stella and Dppa5/ESG1. Nanog was
identified based on a digital differential display strategy
that identified 15 other genes that are enriched or specific to
ES cells. Many of these are also expressed in human ES
cells (Bhattacharya et al., 2004), confirming that additional
pathways exist and remain to be characterized. A detailed
cross species comparison is likely to provide important
insights.
Many but not all of these pathways are likely conserved
between species. Differences in gene expression and
regulation have been reported though the number and extent
of these differences remain unknown as no comprehensive
cross species comparisons have been undertaken. Some of
these comparisons are technically difficult currently as
neither markers, microarrays, nor genomic data sets are
available at a resolution that would allow such a compa-
rison. However, several differences reported have been in
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cells. For example, Oct3/4 homologues likely do not exist in
chicken embryos (Soodeen-Karamath and Gibbins, 2001),
while LIF signaling that is critical for ES cell self-renewal in
mice does not appear to be critical or even required for
human ES cells (see for example Ginis et al., 2004). No
paralogs of E-Hox have been identified in humans, and Eras
appears to be a pseudogene in humans (Bhattacharya et al.,
2004). A list of known differences is summarized in Table 3.
As can be seen, this include genes that have become
redundant during evolution, factors that have been recruited
to different functions, and gene expression patterns that
have been flipped. It is useful to remember that this was not
entirely unexpected given known differences in hemato-
poietic and neural stem cell populations across species
(Ginis and Rao, 2003). However, the number of differences
reported from limited comparisons was quite surprising. It
suggests to us that additional mechanisms driving change,
perhaps evolutionary pressure for speciation, may underlie
the larger than expected difference observed. In any case,
however, it is clear that the self-renewal state of ES cells can
be achieved by multiple independent pathways and different
species likely use overlapping but distinct strategies for self-
renewal. Inter-species comparisons therefore will continue
to be illuminating. The low overall concordance rate
between human and mouse ES cells (in one comparison
was around 40%) relative to that seen in human-to-human
cell comparisons (90% between human ES cell samples)
provides additional support for this hypothesis (Wei et al.,
personal communication). Given that approximately 25% of
all genes identified as being expressed in human cells were
genes of unknown function (Brandenberger et al., 2004b), it
is likely that an additional large number of differentially
expressed genes exist of which a significant number will be
functionally important but divergent.Summary
Progress in our understanding of ES cell biology has
provided crucial insights into the mechanisms of self-
renewal and differentiation. Perhaps the most important
insights have been the determination that species-specific
pathways to ES cell self-renewal exist and that additional
pathways remain to be discovered. We expect that large-
scale genomic comparisons between species and across
stages of differentiation will provide a better understanding
of the interaction between known and unknown pathways
and the role of heterochronic genes, microRNAs, antisense,
polycomb repressors, genes involved in telomere length
regulation, and other poorly characterized modulators of
self-renewal. Further detailed analysis of conserved and
divergent pathways may suggest strategies to isolate ES cell
lines from difficult to isolate species and provide informa-
tion on how to monitor cells in culture. These observations
highlight both the importance as well as the caveats ofextrapolating across species and emphasize the remarkable
divergence in the expression of genes that are critical to
maintaining the ES cell state.Acknowledgments
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